May 15, 2019 / 08:00PM GMT
Jason Matthew Gerberry - BofA Merrill Lynch, Research Division - MD in US Equity Research
My name is Jason Gerberry. I'm the U.S. pharma analyst here at Bank of America. I'm pleased to be introducing AbbVie. I'm joined by Mike Severino, Vice Chairman and President; and Rob Michael, Chief Financial Officer. So gentlemen, thank you so much for joining us at our conference.
Michael E. Severino - AbbVie Inc. - Vice Chairman & President
Pleasure to be here.
Robert A. Michael - AbbVie Inc. - Senior VP & CFO
Thanks for having us.
Questions and Answers:
Jason Matthew Gerberry - BofA Merrill Lynch, Research Division - MD in US Equity ResearchYes. So in terms of the questions, it's probably not a surprise to focus on immunology and your hematology franchises and either your recent launches and your pipeline. So maybe we can start on the immunology side and your recent launch of SKYRIZI. I think as we think about this story, what probably caught a lot of the investors'
Trustpilot
